v3.26.1
Note 2 - Significant Accounting Policies (Tables)
3 Months Ended
Mar. 31, 2026
Notes Tables  
Segment Reporting [Table Text Block]
  

Three months ended

 
  

March 31,

 
  

2026

  

2025

 

Operating expenses

        

Research and development

 $(4,544) $(13,666)

General and administrative

  (6,624)  (10,920)

Other segment items(a)

  837   1,183 

Net loss

 $(10,331) $(23,403)
    
  

March 31, 2026

  

December 31, 2025

 

Cash and cash equivalents

 $86,573  $95,502 
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]
  

Three months ended

 
  

March 31,

 
  

2026

  

2025

 

Numerator:

        

Net loss

 $(10,331) $(23,403)

Denominator:

        

Shares used in computing net loss per share, basic and diluted

  48,308   48,262 

Net loss per share, basic and diluted

 $(0.21) $(0.48)
         

Dilutive common stock options excluded from net loss per share, diluted

  3,972   3,751 

Dilutive Performance Awards excluded from net loss per share, diluted

  7   7